Precogify Pharmaceutical China Co.
Latest round
- Series A
Last raised
- Feb 2022
Total raised
- Undisclosed
Investors
- 4
About Precogify Pharmaceutical China Co.
, also known as Zhongjing Pukang operates as a tumours screening service provider that offers assessment models for cancer risk. Using mass spectrometry testing as a platform and relying on self-developed disease mechanism data discovery technology (B-GPS), the company focuses on metabolomic testing research, development and clinical application for early tumours screening and precision treatment. The company's cancer risk assessment model can be used to detect colorectal cancer, gastrointestinal tumours, and other pan-cancer early screening. The company generates revenue by offering a range of cancer risk assessment models and early tumour screening services.
Who invested in Precogify Pharmaceutical China Co.
4 investors across 2 rounds
See all investors in Precogify Pharmaceutical China Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Precogify Pharmaceutical China Co.
Who invested in Precogify Pharmaceutical China Co.?
Precogify Pharmaceutical China Co. has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Precogify Pharmaceutical China Co. raised?
Precogify Pharmaceutical China Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Precogify Pharmaceutical China Co. last raise money?
Precogify Pharmaceutical China Co.'s most recent round on record is a Series A, in Feb 2022.
What does Precogify Pharmaceutical China Co. do?
, also known as Zhongjing Pukang operates as a tumours screening service provider that offers assessment models for cancer risk.
Where is Precogify Pharmaceutical China Co. headquartered?
Precogify Pharmaceutical China Co. is headquartered in Beijing, China.
Which VCs invest in companies like Precogify Pharmaceutical China Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Precogify Pharmaceutical China Co.'s stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like Precogify Pharmaceutical China Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.